Mon, April 12, 2021
Fri, April 9, 2021
Thu, April 8, 2021

Anita Dushyanth Initiated (BTAI) at Strong Buy and Held Target at $75 on, Apr 9th, 2021

Anita Dushyanth of Berenberg, Initiated "BioXcel Therapeutics, Inc." (BTAI) at Strong Buy and Held Target at $75 on, Apr 9th, 2021.

Anita has made no other calls on BTAI in the last 4 months.



There are 4 other peers that have a rating on BTAI. Out of the 4 peers that are also analyzing BTAI, 0 agree with Anita's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Anita


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $175 on, Thursday, April 1st, 2021
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Decreased Target to $127 on, Thursday, April 1st, 2021
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $95 on, Thursday, April 1st, 2021
  • Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $99 on, Monday, February 1st, 2021